Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Ranibizumab (Lucentis) for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema Which Has Proven Refractory or Ineligible to Standard Treatment.

NCT01564108 is registered in ClinicalTrials.gov with Moorfields Eye Hospital NHS Foundation Trust as lead sponsor.

NCT NCT01564108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01564108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Ranibizumab (Lucentis) for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema Which Has Proven Refractory or Ineligible to Standard Treatment.
Lead sponsor
Moorfields Eye Hospital NHS Foundation Trust
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2012
Completion date
June 30, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

steroid-induced glaucoma - borderline, uveitis related cystoid macular edema